Ind Swift Laboratories Share Price

₹ 353.25

-₹14.95 (-4.06%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: INDSWFTLAB
|
Pharmaceuticals

Ind Swift Laboratories Share Price Today

As of 3 Nov 2026, Ind Swift Laboratories share price is ₹353.25. The stock opened at ₹366.15, compared to its previous close of ₹368.20. During today's trading session, Ind Swift Laboratories share price moved in the range of ₹346.00 to ₹374.75, with an average price of ₹360.38 for the day. Looking at its last 52-week, the stock has touched a low of ₹87.15 and a high of ₹426.60. On the performance front, Ind Swift Laboratories share price has increased by 156.83% over the last six months and is up 243.93% on a year-on-year basis.

Share price over the last 1 day fell from 374.55 to 353.25, ranging between 351.85 and 374.55.
₹346.00
4.06% down today
₹374.75
1D LOW
1D HIGH

Ind Swift Laboratories Stock Insights

Latest Earning
Op Profit TrendUp by 33.23% QoQ
Latest Earning
Net Profit TrendUp by 38.99% QoQ
Latest Earning
Revenue TrendUp by 24.59% QoQ
Stock Performance
OutperformingBeat Nifty by 69.64 % in last 3 month
Shareholding Pattern
DIIDII increased stake by 18.03%
Shareholding Pattern
FIIFII increased stake by 0.70%
Ind Swift Laboratories stock performance
Open₹366.15
High₹374.75
Low₹346.00
Prev. close₹368.20
Ind Swift Laboratories trading activity
Volume7,68,932
Average traded price₹359.41
Last traded time03:29:59 02 Nov
Last traded quantity2
Circuit
L
H
₹294.60
₹441.80
52-week
L
H
₹87.15
₹426.60
Mkt Cap Cr
3,194.97
P/E
38.23
P/B
2.17
ROA
4.71%
ROE
6.22%
ROCE
7.76%
Quick Ratio
3.22
EV/EBITDA
21.05

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Ind-Swift Labs. has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Ind-Swift Labs. appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Ind-Swift Labs. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Ind Swift Laboratories Company Background

ISIN
INE915B01019
Sector Market Cap
₹ 3,194.97 Cr

Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.

Ind Swift Laboratories Financial Highlights

  • Revenue: Ind Swift Laboratories reported revenue of ₹696.11 crore in FY26 vs ₹643.09 crore in FY25. It showed an increase of 8.24% on a yearly basis.
  • Operating Profit: Ind Swift Laboratories reported an operating profit of ₹50.76 crore in FY26 vs ₹257.80 crore in FY25. It showed a decrease of 80.31% on a year-on-year basis.
  • Net Profit: Ind Swift Laboratories reported a net profit of ₹43.03 crore in FY26 vs ₹250.53 crore in FY25. It showed a decrease of 82.82% on a yearly basis.

Ind Swift Laboratories Quarterly Result Highlights

  • Ind Swift Laboratories reported revenue of ₹248.06 crore in Sep 2026, compared with ₹199.10 crore in Jun 2026, representing an increase of 24.59% on a quarter-on-quarter (QoQ) basis.
  • Ind Swift Laboratories reported an operating profit of ₹43.38 crore in Sep 2026, compared with ₹32.56 crore in Jun 2026, representing an increase of 33.23% on a quarter-on-quarter (QoQ) basis.
  • Ind Swift Laboratories reported a profit of ₹34.15 crore in Sep 2026, compared with ₹24.57 crore in Jun 2026, reflecting an increase of 38.99% on a QoQ basis.
  • The earnings per share (EPS) of Ind Swift Laboratories stood at ₹5.16 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
42.93%
FII
10.78%
Other DII
0.20%
Retail and other
46.09%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Feb 202613.80%
Mar 202613.88%
Jun 202610.70%
Sep 202610.78%

Ind Swift Laboratories Investment Returns

1 day
-4.06%
1 week
+4.81%
1 month
-10.60%
1 year
+243.93%
3 years
+303.25%
5 years
+426.06%

Ind Swift Laboratories Share Price History

Ind Swift Laboratories share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹366.15 / ₹353.25
-4.06%
30 Oct 26
₹417.90 / ₹368.20
-10.15%
29 Oct 26
₹381.00 / ₹409.80
+8.14%
28 Oct 26
₹376.20 / ₹378.95
+2.75%
Show more

Ind Swift Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹649.14₹574.24₹1,280.90₹1,207.31
Other Income₹46.97₹68.86₹45.37₹33.50
Total Revenue₹696.10₹643.09₹1,326.27₹1,240.81
Total Expenses₹634.34₹608.50₹1,131.10₹1,127.64
Profit Before Tax₹50.76₹257.80₹581.76₹86.52
Tax₹7.73₹7.27₹160.31₹38.69
Profit After Tax₹43.03₹250.53₹421.45₹47.83
EPS - Basic₹5.16₹37.24₹71.24₹8.10
EPS - Diluted₹5.03₹35.21₹71.24₹8.10

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹61.76₹34.59₹195.17₹113.17
Income before WC changes₹41.90-₹2.37₹319.93₹245.95
Change in Assets-₹150.07₹47.29-₹515.89-₹68.39
Change in Liabilities₹46.70-₹67.05₹32.84₹17.07
Change in WC-₹103.37-₹19.76-₹483.05-₹51.33
Cash flow from Operations-₹68.17-₹28.69-₹163.12₹194.62
Cash flow from Investing-₹72.68-₹113.13-₹104.32-₹13.37
Cash flow from Financing₹141.81₹72.42₹698.91-₹185.66
Total Cash Flow₹0.96-₹69.39₹431.48-₹4.41
Cash (Start of the year)₹425.11₹493.93₹18.20₹21.48
Cash (End of the year)₹429.85₹425.11₹449.68₹17.07

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹696.60₹572.99₹503.98₹659.55
Current Assets₹976.75₹865.35₹661.13₹1,164.52
Total Assets₹1,673.35₹1,438.34₹1,165.11₹1,824.06
Current Liabilities₹257.29₹220.58₹221.28₹371.09
Net Current Asset₹719.47₹644.77₹439.85₹793.43
Non-Current Liabilities₹32.10₹44.79₹12.39₹771.04
Equity Capital₹1,383.97₹1,172.97₹931.44₹681.93
Total Equity & Liabilities₹1,673.35₹1,438.34₹1,165.11₹1,824.06

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹635.89₹562.17₹1,672.57₹1,151.96
Other Income₹46.96₹68.75₹88.30₹33.28
Total Revenue₹682.84₹630.92₹1,760.86₹1,185.24
Total Expenses₹621.62₹589.98₹1,557.92₹1,079.39
Profit Before Tax₹50.22₹264.14₹593.93₹79.20
Tax₹7.66₹8.06₹57.76₹36.73
Profit After Tax₹42.56₹256.09₹536.18₹42.47
EPS - Basic₹5.09₹38.07₹90.74₹7.19
EPS - Diluted₹4.97₹36.00₹90.74₹7.19

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹61.22₹40.94₹202.94₹105.85
Income before WC changes₹41.29₹4.02₹378.03₹238.62
Change in Assets-₹119.63-₹7.82-₹526.27-₹73.90
Change in Liabilities₹44.85-₹34.93-₹17.50₹17.95
Change in WC-₹74.79-₹42.75-₹543.77-₹55.95
Cash flow from Operations-₹40.19-₹45.30-₹165.74₹182.67
Cash flow from Investing-₹100.16-₹109.67-₹27.71-₹13.69
Cash flow from Financing₹145.26₹77.44₹657.78-₹168.41
Total Cash Flow₹4.90-₹77.53₹464.33₹0.58
Cash (Start of the year)₹410.09₹487.62₹23.28₹9.38
Cash (End of the year)₹414.99₹410.09₹487.62₹9.96

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹779.43₹628.32₹556.24₹714.20
Current Assets₹874.91₹793.73₹852.16₹1,074.07
Total Assets₹1,654.34₹1,422.05₹1,408.40₹1,788.27
Current Liabilities₹251.55₹216.35₹397.71₹350.05
Net Current Asset₹623.36₹577.38₹454.46₹724.02
Non-Current Liabilities₹32.10₹41.63₹212.55₹762.88
Equity Capital₹1,370.70₹1,164.08₹798.15₹675.35
Total Equity & Liabilities₹1,654.34₹1,422.05₹1,408.40₹1,788.27
* All values are in INR Crore
Ind Swift Laboratories market depth
Bid quantityBid priceAsk priceAsk quantity
00353.25603
0000
0000
0000
0000
Total bid quantity0
Total ask quantity603
Ind Swift Laboratories technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
50.48
Neutral
ATR (14)
28.5
Neutral
STOCH(9,6)
47.2
Neutral
STOCH RSI (14)
54.12
Neutral
ADX(9)
30.31
Bearish
UO(9)
51.26
Neutral
ROC(12)
1.9
Bullish
WillR(14)
-52.8
Neutral
Period
Simple value
Exponential vaue
5D
372.56
373.74
10D
358.93
367.77
20D
366.94
367.49
50D
370.01
351.49
100D
296.3
307.6
Volume trend — traded volume by day
2 Nov7L
30 Oct36L
29 Oct35L
28 Oct5L
27 Oct8L
Average18L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Ind Swift Laboratories
Pharmaceuticals
Add Stock
Add Another

Ind Swift Laboratories Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

Ind Swift Laboratories Share Price FAQs

Please be aware that Ind Swift Laboratories stock prices are subject to continuous fluctuations due to various factors.